CCWM
IDXX icon

Cassaday & Co Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Cassaday & Co Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$562 – 1373
2026
Q1 		$562 Buy
+1
New +$641 ﹤0.01% 1181

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cassaday & Co Wealth Management's IDXX Position: Q2 2026 in Review

Cassaday & Co Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1 share — an estimated $562 sold.

Cassaday & Co Wealth Management first reported a position in IDXX in Q1 2026 and held it in 1 quarter. The position peaked at $562 in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cassaday & Co Wealth Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Cassaday & Co Wealth Management sold 1 Idexx Laboratories share in Q2 2026, an estimated $562.
  • Cassaday & Co Wealth Management first reported a position in Idexx Laboratories in Q1 2026 and held it in 1 quarter.
  • Cassaday & Co Wealth Management's Idexx Laboratories position peaked at $562 in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.